84 results
S-1/A
EX-99.1
CELU
Celularity Inc - Ordinary Shares
13 May 19
IPO registration (amended)
4:55pm
has the direct authority and responsibility to appoint, retain, compensate, terminate, select, evaluate and, where appropriate, replace … (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit, as required
8-K
EX-10.2
CELU
Celularity Inc - Ordinary Shares
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
evidence that the Company is entitled to said funds, and the Trustee shall have no responsibility to look beyond said request;
(k) Upon written request … that the Company is entitled to distribute said funds, and the Trustee shall have no responsibility to look beyond said request; and
(l) Not make any
S-1/A
EX-10.3
CELU
Celularity Inc - Ordinary Shares
13 May 19
IPO registration (amended)
4:55pm
evidence that the Company is entitled to said funds, and the Trustee shall have no responsibility to look beyond said request;
(k) Upon written request … that the Company is entitled to distribute said funds, and the Trustee shall have no responsibility to look beyond said request; and
(l) Not make any withdrawals
8-K
EX-10.2
CELU
Celularity Inc - Ordinary Shares
24 May 19
GX Acquisition Corp. Announces Pricing of $250,000,000 Initial Public Offering
5:00pm
evidence that the Company is entitled to said funds, and the Trustee shall have no responsibility to look beyond said request;
(k) Upon written request … that the Company is entitled to distribute said funds, and the Trustee shall have no responsibility to look beyond said request; and
(l) Not make any
8-K
CELU
Celularity Inc - Ordinary Shares
6 Oct 22
Departure of Directors or Certain Officers
4:08pm
development and technical operations. Prior to Kite, Dr. Glover he held several roles of increasing responsibility at Genentech, Inc. (now part of the Roche
8-K
EX-99.1
b029 up60guf7ln8d
30 May 19
GX Acquisition Corp. Index to Financial Statement
4:11pm
S-1/A
EX-99.2
ygwno9mm
13 May 19
IPO registration (amended)
4:55pm
S-4
EX-10.14
j0e6b cpb88ii7
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4
EX-10.32
snotjj 1hbuwtt5f9
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
S-4/A
EX-10.9
rwz341y
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-1/A
EX-14
82b7m6bhmiianzvnc2
13 May 19
IPO registration (amended)
4:55pm
S-1
EX-3.3
al902 5gc
26 Apr 19
IPO registration
4:23pm
8-K
EX-3.2
6yoxtgcgz2z g3e
22 Jul 21
Celularity Closes Merger with GX Acquisition Corp and Provides Corporate Update
4:13pm
DRS
EX-3.3
ki15glqpfsaw6bp ok
5 Nov 18
Draft registration statement
12:00am
8-K
EX-10.3
uk63krw y3
6 Apr 23
Celularity Inc. Announces $6 Million Registered Direct Offering
8:58pm
8-K
EX-10.3
wcvw1gw
28 Jul 23
Celularity Inc. Announces $3 Million Registered Direct Offering
4:27pm
8-K
EX-10.4
3amva7kii3g0gd 5q0
20 May 22
Celularity Inc. Announces $30 Million Private Placement
4:06pm
S-4/A
EX-10.26
lemen r1e62vupagpb
29 Mar 21
Registration of securities issued in business combination transactions (amended)
7:30am
S-4
EX-10.11
tifs63
25 Jan 21
Registration of securities issued in business combination transactions
4:51pm
424B3
lzyfy9uhv lp7
2 Jun 23
Prospectus supplement
5:00pm